Cancer treatments first tested ‘in silico’
Thursday, 24 February, 2022
Share
Development of ‘digital twins’ at SBI can help doctors aim for new definition of ‘cure’, which sees children with cancer living without severe side effects and also key to assessing risk of treatment resistance